Showing results (241-250 of 293) with videos related to

Sort By:
Pageof 30
Haematologica|July 13, 2019
Daratumumab displays in vitro and in vivo anti-tumor activity in models of B-cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimensAnna Vidal-Crespo, Alba Matas-Céspedes, Vanina Rodriguez, et al.
Vaccine|February 25, 2022
Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshopEloise Williams, Kathrine Craig, Christopher Chiu, et al.
Plos Neglected Tropical Diseases|January 9, 2026
Proceedings of the inaugural symposium on dengue human challenge studies "Challenging the norm: Accelerating dengue countermeasures through human studies"Shirin Kalimuddin, Adam T Waickman, Panisadee Avirutnan, et al.
The Lancet. Healthy Longevity|September 13, 2022
Divergent age-related humoral correlates of protection against respiratory syncytial virus infection in older and young adults: a pilot, controlled, human infection challenge modelStephanie Ascough, Pete Dayananda, Mohini Kalyan, et al.
Haematologica|June 22, 2019
Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age: subgroup analysis of the phase 3 CASTOR and POLLUX studiesMaria-Victoria Mateos, Andrew Spencer, Ajay K Nooka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2021
Evaluation of Sustained Minimal Residual Disease Negativity With Daratumumab-Combination Regimens in Relapsed and/or Refractory Multiple Myeloma: Analysis of POLLUX and CASTORHervé Avet-Loiseau, Jesus San-Miguel, Tineke Casneuf, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 12, 2018
High-Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of ActionHomer C Adams, Frederik Stevenaert, Jakub Krejcik, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2014
Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humansAli H Ellebedy, Florian Krammer, Gui-Mei Li, et al.
Nature Medicine|August 31, 2023
Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalizationMaxime Taquet, Zuzanna Skorniewska, Adam Hampshire, et al.
Nature Communications|December 22, 2015
RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infectionAgnieszka Jozwik, Maximillian S Habibi, Allan Paras, et al.
Pageof 30